CDC anthrax vaccine safety & efficacy research program : interim report /

Mostrar otras versiones (1)

Anthrax in its inhalational form is a deadly but very rare manifestation of infection with a common organism, Bacillus anthracis. Anthrax spores are very stable, a characteristic that makes possible their delivery as a weapon of biological warfare, and examples of weapons development efforts using a...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: Institute of Medicine (U.S.). Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program (Autor)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, DC : National Academy Press, [2001]
Temas:
Centers for Disease Control and Prevention (U.S.)
Anthrax > Vaccination.
Vaccines > Effectiveness.
Vaccines > Safety measures.
Anthrax Vaccines
Anthrax > prevention & control
Drug Evaluation
Program Evaluation
Vaccins > Efficacité.
Vaccins > Sécurité > Mesures.
MEDICAL > Infectious Diseases.
HEALTH & FITNESS > Diseases > Contagious.
United States
Acceso en línea:Texto completo
Descripción
Sumario:Anthrax in its inhalational form is a deadly but very rare manifestation of infection with a common organism, Bacillus anthracis. Anthrax spores are very stable, a characteristic that makes possible their delivery as a weapon of biological warfare, and examples of weapons development efforts using anthrax are well known. It is important to protect the men and women in our armed services to the greatest extent possible. The Department of Defense (DoD) established the Anthrax Vaccine Immunization Program (AVIP) in order to do so; however, some parties have raised questions about the safety and even the efficacy of the vaccine. As a result, the DoD is sponsoring an Institute of Medicine (IOM) study of the safety and efficacy of the vaccine, and Congress has instructed the Centers for Disease Control and Prevention (CDC) to conduct further safety and efficacy research. The CDC contracted with the IOM to review their research program for completeness and appropriateness. This document is an interim report of the Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program, and reflects only a preliminary review of a program still in development.
Notas:Title from PDF title page.
"Prepublication Copy, Uncorrected Proofs"--PDF title page
Descripción Física:1 online resource (1 PDF file (xii, 45 pages)) : illustrations
Bibliografía:Includes bibliographical references.
ISBN:0309579872
9780309579872
1280248041
9781280248047

Ejemplares similares